Omics Sequencing Market Size, Report by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Omics Sequencing Market

5.1. COVID-19 Landscape: Omics Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Omics Sequencing Market, By Technology

8.1. Omics Sequencing Market, by Technology

8.1.1. Next-Generation Sequencing (NGS)

8.1.1.1. Market Revenue and Forecast

8.1.2. Whole Genome Sequencing (WGS)

8.1.2.1. Market Revenue and Forecast

8.1.3. Whole Exome Sequencing (WES)

8.1.3.1. Market Revenue and Forecast

8.1.4. RNA Sequencing (Transcriptomics)

8.1.4.1. Market Revenue and Forecast

8.1.5. Single-Cell Sequencing

8.1.5.1. Market Revenue and Forecast

8.1.6. Epigenomic Sequencing

8.1.6.1. Market Revenue and Forecast

8.1.7. Proteomics and Metabolomics Sequencing

8.1.7.1. Market Revenue and Forecast

8.1.8. Sanger Sequencing (legacy use)

8.1.8.1. Market Revenue and Forecast

Chapter 9. Global Omics Sequencing Market, By Component

9.1. Omics Sequencing Market, by Component

9.1.1. Instruments and Sequencing Platforms

9.1.1.1. Market Revenue and Forecast

9.1.2. Dessert

9.1.2.1. Market Revenue and Forecast

9.1.3. Reagents and Consumables

9.1.3.1. Market Revenue and Forecast

9.1.4. Software and Bioinformatics Tools

9.1.4.1. Market Revenue and Forecast

9.1.5. Sequencing Services

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Omics Sequencing Market, By Application

10.1. Omics Sequencing Market, by Application

10.1.1. Clinical Diagnostics (cancer, rare diseases, infectious diseases)

10.1.1.1. Market Revenue and Forecast

10.1.2. Drug Discovery and Development

10.1.2.1. Market Revenue and Forecast

10.1.3. Precision Medicine and Personalized Healthcare

10.1.3.1. Market Revenue and Forecast

10.1.4. Agricultural and Plant Genomics

10.1.4.1. Market Revenue and Forecast

10.1.5. Microbiome and Metagenomics

10.1.5.1. Market Revenue and Forecast

10.1.6. Forensics and Veterinary Genomics

10.1.6.1. Market Revenue and Forecast

10.1.7. Academic and Research Studies

10.1.7.1. Market Revenue and Forecast

Chapter 11. Global Omics Sequencing Market, By End-User

11.1. Omics Sequencing Market, by End-User

11.1.1. Academic and Research Institutions

11.1.1.1. Market Revenue and Forecast

11.1.2. Hospitals and Clinical Laboratories

11.1.2.1. Market Revenue and Forecast

11.1.3. Pharmaceutical and Biotechnology Companies

11.1.3.1. Market Revenue and Forecast

11.1.4. Contract Research Organizations (CROs)

11.1.4.1. Market Revenue and Forecast

11.1.5. Agriculture and Environmental Research Centers

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Omics Sequencing Market, By Distribution Model

12.1. Omics Sequencing Market, by Distribution Model

12.1.1. Direct Sales (manufacturers to labs and institutions)

12.1.1.1. Market Revenue and Forecast

12.1.2. Distributors and Value-Added Resellers

12.1.2.1. Market Revenue and Forecast

12.1.3. Sequencing-as-a-Service (outsourced labs and genomics service providers)

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Omics Sequencing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology

13.1.2. Market Revenue and Forecast, by Component

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by End-User

13.1.5. Market Revenue and Forecast, by Distribution Model

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology

13.1.6.2. Market Revenue and Forecast, by Component

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by End-User

13.1.6.5. Market Revenue and Forecast, by Distribution Model

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology

13.1.7.2. Market Revenue and Forecast, by Component

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by End-User

13.1.7.5. Market Revenue and Forecast, by Distribution Model

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology

13.2.2. Market Revenue and Forecast, by Component

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by End-User

13.2.5. Market Revenue and Forecast, by Distribution Model

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology

13.2.6.2. Market Revenue and Forecast, by Component

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by End-User

13.2.8. Market Revenue and Forecast, by Distribution Model

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology

13.2.9.2. Market Revenue and Forecast, by Component

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by End-User

13.2.11. Market Revenue and Forecast, by Distribution Model

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology

13.2.12.2. Market Revenue and Forecast, by Component

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by End-User

13.2.13. Market Revenue and Forecast, by Distribution Model

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology

13.2.14.2. Market Revenue and Forecast, by Component

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by End-User

13.2.15. Market Revenue and Forecast, by Distribution Model

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology

13.3.2. Market Revenue and Forecast, by Component

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by End-User

13.3.5. Market Revenue and Forecast, by Distribution Model

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology

13.3.6.2. Market Revenue and Forecast, by Component

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by End-User

13.3.7. Market Revenue and Forecast, by Distribution Model

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology

13.3.8.2. Market Revenue and Forecast, by Component

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by End-User

13.3.9. Market Revenue and Forecast, by Distribution Model

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology

13.3.10.2. Market Revenue and Forecast, by Component

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by End-User

13.3.10.5. Market Revenue and Forecast, by Distribution Model

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology

13.3.11.2. Market Revenue and Forecast, by Component

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by End-User

13.3.11.5. Market Revenue and Forecast, by Distribution Model

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology

13.4.2. Market Revenue and Forecast, by Component

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by End-User

13.4.5. Market Revenue and Forecast, by Distribution Model

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology

13.4.6.2. Market Revenue and Forecast, by Component

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by End-User

13.4.7. Market Revenue and Forecast, by Distribution Model

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology

13.4.8.2. Market Revenue and Forecast, by Component

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by End-User

13.4.9. Market Revenue and Forecast, by Distribution Model

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology

13.4.10.2. Market Revenue and Forecast, by Component

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by End-User

13.4.10.5. Market Revenue and Forecast, by Distribution Model

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology

13.4.11.2. Market Revenue and Forecast, by Component

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by End-User

13.4.11.5. Market Revenue and Forecast, by Distribution Model

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology

13.5.2. Market Revenue and Forecast, by Component

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by End-User

13.5.5. Market Revenue and Forecast, by Distribution Model

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology

13.5.6.2. Market Revenue and Forecast, by Component

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by End-User

13.5.7. Market Revenue and Forecast, by Distribution Model

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology

13.5.8.2. Market Revenue and Forecast, by Component

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by End-User

13.5.8.5. Market Revenue and Forecast, by Distribution Model

Chapter 14. Company Profiles

14.1. 10x Genomics

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BGI Group/MGI Tech Co.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bio-Rad Laboratories

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bruker

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Danaher Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Eurofins Scientific

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche Ltd.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Illumina

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. LGC Limited

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The major players in the omics sequencing market include 10x Genomics, Agilent Technologies, BGI Group/MGI Tech Co., Bio-Rad Laboratories, Bruker, Danaher Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, LGC Limited, Merck KGaA, New England Biolabs, Novogene Co., Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences (PacBio), PerkinElmer, Promega Corporation, QIAGEN, Takara Bio Inc., and Thermo Fisher Scientific.

The driving factors of the omics sequencing market are the advancements in genomics, proteomics, and transcriptomics, enabling precision medicine, drug discovery, and personalized healthcare solutions across diverse clinical and research applications worldwide.

North America region will lead the global omics sequencing market during the forecast period 2025 to 2034.